NASS 2017 Annual Meeting

Cerapedics, Inc. 

Booth 533

Romansville, PA  
      United States



Cerapedics is an orthobiologics company focused on developing and commercializing novel bone grafts that enhance and accelerate bone growth in a variety of orthopedic procedures. i-FACTOR Bone Graft, the company's lead product, is the only biologic bone graft that utilizes a synthetic small peptide (P-15) bound to an anorganic bone mineral (ABM). i-FACTOR is also the only FDA approved (PMA recieved November 2015) drug/device combination bone graft for use in cervical interbody fusion. The novel “Attract, Attach, Activate” mechanism of action enhances the body’s natural bone healing process, resulting in bone formation that is predictably bound to the surface of the bone graft.



 


Product Categories

Biomaterials
- Bone Graft Matrix
- Peptide Enhanced Bone Graft

Fusion
- Anterior Cervical Discectomy and Fusion (ACDF)
- Spine Fusion

Implants
- Biomaterials

Spine Biologics
- Peptide Enhanced Bone Graft